Staff Profile
Dr Tony Sorial
NIHR Clinical Lecturer in Trauma and Orthopaedics
- Personal Website: https://orcid.org/0000-0002-4449-014X
I am an academic orthopaedic surgeon with a focus on arthritis and ageing research. I undertook undergraduate training (MBChB - Medicine and Surgery, MSc - Tissue Engineering for Regenerative Medicine) at The University of Manchester, with my research project focussing on optimising culture conditions to enhance the differentiation of Mesenchymal Stem Cells (MSCs) into cartilage. As a post-graduate I completed the NIHR Academic Foundation Programme (North West) and in 2016 was appointed as an NIHR Academic Clinical Fellow in Trauma and Orthopaedics in the Northern Deanery.
Since 2016, I have focussed on understanding the genetics and epigenetics of disabling musculoskeletal diseases (mainly osteoarthritis). I aim to apply this knowledge, and CRISPR-based genome editing tools, to develop novel therapies from MSCs and Human induced Pluripotent Stem Cells (HiPSCs). In future, this work aims to develop pathways for the production and validation of genetically resilient cartilage from human cell sources to treat osteoarthritis.
I was awarded the 2020-21 Royal College of Surgeons UK-US Fulbright scholar award (http://www.fulbright.org.uk/about-us/meet-our-fulbrighters/2020-21-us-uk-fulbright-award-grantees/2020-21-british-scholar-award-grantees) to support my PhD work in Missouri with Farshid Guilak (https://orthopaedicresearch.wustl.edu/labs/farshid-guilak/).
I completed my PhD In June 2024 and was awarded and NIHR Clinical Lectureship in Trauma and Orthopaedics to facilitate protected research time from 2024-2028.
My MRes dissertation title (2013) was “Influence of culture conditions on Mesenchymal Stem Cell expansion and differentiation: implications for cartilage tissue engineering” and my PhD thesis title (2024) was "Development and validation of novel CRISPR based genome and epigenome editing pipelines to elucidate and modulate osteoarthritis risk”.
Key Collaborators
- Professors John Loughlin & David Deehan - Newcastle University (genetics, epigenetics & surgical translation)
- Professor Judith Hoyland - The University of Manchester (matrix biology)
- Professor Farsh Guilak - Washington University in St Louis, Missouri, USA (cartilage regeneration from MSCs and HiPSCs, mechanobiology, single cell RNA sequencing)
- Professor Gerhard Wiche - Universität Wien, Vienna, Austria (cytoskeletal biology, plectinopathies)
- Professor Miles Witham (Newcastle Univeristy) - sarcopenia, hip fracture outcomes, ageing and surgical frailty
- Professor Mike Reed - surgical outcomes
Specialty Interests
- Molecular genetics and epigenetics
- DNA Methylation analyses
- CRISPR-Cas9/dCas9 genome and epigenome editing
- MSC and HiPSC chondrogenesis
- Mechanobiology
- Tissue engineering and regeneration
- RNA sequencing including single cell (scRNA-Seq)
- Visualising the cellular cytoskeleton
- Patient and public involvement / engagement (PPI/E)
- Outcomes research
- Orthogeriatric research
My research has been supported by:
UK-US Fulbright Commission
Wellcome Trust
The Medical Research Council (MRC) Versus Arthritis Centre for Integrated research into Musculoskeletal Ageing (CIMA)
Royal College of Surgeons of England
Royal College of Surgeons of Edinburgh
The John George William Patterson Foundation
The John Charnley Trust
Wrightington 3 Wishes Foundation
Leopharma Scholarship
JHG Holt Foundation
MRC
Newcastle upon Tyne Hospitals Charity
United States Government National Institutes of Health (NIH)
More information is available @
My research falls under two broad themes:
1) Basic science/translational
In this theme my research focusses on the genetics and epigenetics of disabling musculoskeletal disease, and how our understanding of this can be used to create genome edited, tissue engineered solutions to disease.
My research is collaborative and forms links between Newcastle University, The University of Manchester, Washington University in St Louis (MO, USA) and Universitat Wien (Vienna, AT).
2) Surgical frailty and outcomes research
In this theme I work closely with the AGE research group (Newcastle NIHR BRC), Northumbria Healthcare NHS Foundation Trust and Newcastle upon Tyne Hospitals NHS foundation trust. The overarching aim is to use existing data to develop algorithms to predict (and eventually improve) outcomes from orthopaedic surgery. We are interested in sarcopenia, and low muscle mass, as markers of sub-clinical frailty, and how these may predict outcomes. We initially focussed on hip fracture research but we are now looking at elective surgery.
I co-supervise projects (in collaboration with colleagues) in both basic science and other fields of orthopaedic/translational research.
Our previous intercalcated MR4es students have achieved first author publications, distinctions in intercalated MSc programmes and appointments to the nationally competetive NIHR specialised foundation programme (SFP).
I am happy to consider mentoring and supervising MRes/medical students/ post-graduate medics/PhD students. Please contact me by email (tony.sorial@ncl.ac.uk) if you are interested in getting involved in research.
-
Articles
- Prowse J, Jaiswal S, Gentle J, Witham MD, Sorial AK. Feasibility, acceptability and prognostic value of muscle mass and strength measurement in patients with hip fracture: a systematic review. European Geriatric Medicine 2024. In Press.
- Stubbs TA, Doherty WJ, Chaplin A, Langford S, Reed MR, Sayer AA, Witham MD, Sorial AK. Using pre-fracture mobility to augment prediction of post-operative outcomes in hip fracture. European Geriatric Medicine 2023, 14, 285–293.
- The Collaborative Orthopaedic Research Network (CORNET) Study Group, Sorial AK. A prospective multi-centre observational cohort study to evaluate frequency, management and outcomes of acute severe (grade III–VI) acromioclavicular joint injuries in the United Kingdom. Shoulder and Elbow 2023, 15(4), 381-389.
- Surgeons in Training Association, Sorial AK. Nominal group consensus process to determine Association of Surgeons in Training quality indicators for integrated clinical academic surgical training across the UK. BJS Open 2022, 6(2), zrac048.
- Sorial AK, Harrison-Holland M, Young HS. The impact of research intercalation during medical school on post-graduate career progression. BMC Medical Education 2021, 21, 39.
- Doherty WJ, Stubbs TA, Chaplin A, Reed MR, Sayer AA, Witham MD, Sorial AK. Prediction of postoperative outcomes after hip fracture surgery: independent validation and recalibration of the Nottingham Hip Fracture Score. Journal of American Medical Directors Association 2021, 22(3), 663-669.e2.
- Doherty WJ, Stubbs TA, Chaplin A, Langford S, Sinclair N, Ibrahim K, Reed MR, Sayer AA, Witham MD, Sorial AK. Implementing grip strength assessment in hip fracture patients: a feasibility project. Journal of Frailty, Sarcopenia and Falls 2021, 6(2), 66-78.
- Sorial AK, Anjum SA, Cook MJ, Board TN, ONeill TW. Statins, Bone Biology and Revision Arthroplasty: Review of Clinical and Experimental Evidence. Therapeutic Advances in Musculoskeletal Disease 2020, 12.
- Sorial AK, Hofer IM, Tselepi M, Cheung K, Parker E, Deehan DJ, Rice SJ, Loughlin J. Multi-tissue epigenetic analysis of the osteoarthritis susceptibility locus mapping to the plectin gene PLEC. Osteoarthritis and Cartilage 2020, 28(11), 1448-1458.
- Cook M, Sorial AK, Lunt M, Board TN, O'Neill TW. Effect of timing and duration of statin exposure on risk of hip or knee revision arthroplasty: a population-based cohort study. The Journal of Rheumatology 2020, 47(3), 441-448.
- Rice SJ, Tselepi M, Sorial AK, Aubourg G, Shepherd C, Almarza D, Skelton AJ, Pangou I, Deehan DJ, Reynard L, Loughlin J. Prioritization of PLEC and GRINA as osteoarthritis risk genes through the identification and characterization of novel methylation quantitative trait loci. Arthritis and Rheumatology 2019, 71(8), 1285-1296.
- Rice SJ, Aubourg G, Sorial AK, Almarza D, Tselepi M, Deehan DJ, Reynard LN, Loughlin J. Identification of a novel, methylation-dependent, RUNX2 regulatory region associated with osteoarthritis risk. Human Molecular Genetics 2018, 27(19), 3464-3474.
- Mohan HM, Fitzgerald E, Gokani V, Sutton P, Harries R, Bethune R, McDermott FD, Sorial A, Collaborators A. Engagement and role of surgical trainees in global surgery: Consensus statement and recommendations from the Association of Surgeons in Training. International Journal of Surgery 2018, 52, 366-370.
-
Conference Proceedings (inc. Abstracts)
- Rice SJ, Sorial AK, Aubourg G, Shepherd C, Tselepi M, Almarza D, Skelton AJ, Deehan D, Reynard LN, Loughlin J. Identification of novel methylation quantitative trait loci (mqtls) and functional characterization using CRISPR/CAS9 and gene expression analysis prioritizes PLEC as an OA risk gene. In: 2018 OARSI World Congress on Osteoarthritis Promoting Clinical and Basic Research in Osteoarthritis. 2018, Liverpool: Elsevier.
- Rice SJ, Aubourg G, Sorial AK, Deehan D, Loughlin J, Reynard LN. Epigenetic and transcriptional effects operate on the SUPT3H and RUNX2 genes residing at the chromosome 6p21.1 osteoarthritis susceptibility locus and correlate with the association signal. In: 2017 OARSI World Congress. 2017, Las Vegas, NV, USA.